GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Protara Therapeutics Inc (STU:1KPA) » Definitions » Other Gross PPE

Protara Therapeutics (STU:1KPA) Other Gross PPE : €5.73 Mil (As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Protara Therapeutics Other Gross PPE?

Protara Therapeutics's Other Gross PPE for the quarter that ended in Mar. 2024 was €5.73 Mil.

Protara Therapeutics's quarterly Other Gross PPE declined from Sep. 2023 (€6.53 Mil) to Dec. 2023 (€6.22 Mil) and declined from Dec. 2023 (€6.22 Mil) to Mar. 2024 (€5.73 Mil).

Protara Therapeutics's annual Other Gross PPE declined from Dec. 2021 (€7.61 Mil) to Dec. 2022 (€7.36 Mil) and declined from Dec. 2022 (€7.36 Mil) to Dec. 2023 (€6.22 Mil).


Protara Therapeutics Other Gross PPE Historical Data

The historical data trend for Protara Therapeutics's Other Gross PPE can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Protara Therapeutics Other Gross PPE Chart

Protara Therapeutics Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Other Gross PPE
Get a 7-Day Free Trial 0.41 1.94 7.61 7.36 6.22

Protara Therapeutics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Other Gross PPE Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.07 6.69 6.53 6.22 5.73

Protara Therapeutics Other Gross PPE Calculation

GuruFocus lists Land And Improvements, Buildings And Improvements, Machinery, Furniture, Equipment, Construction In Progress and Other Gross PPE under the "Gross Property, Plant and Equipment" section.


Protara Therapeutics (STU:1KPA) Business Description

Traded in Other Exchanges
Address
345 Park Avenue South, 3rd Floor, New York, NY, USA, 10010
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with rare and specialty diseases. The company discovers, develops, and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).

Protara Therapeutics (STU:1KPA) Headlines

No Headlines